Important: Hydroxycut Legal Actions Have Recently Been Filed
On May 1, 2009, there was a recall of fourteen Hydroxycut diet-aid products stemming from a number of reports that people using the products were developing major liver problems and other health issues. Less than 7 days later, on May 4, the first Hydroxycut class action suit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Class Action Lawsuit alleges company failure in informing the public about potential risks of the products. Naturally, it’s too soon to know how the suit is going to turn out, but if the company had information which it didn’t divulge to buyers, it should definitely be held accountable.
A class action legal action is filed by a bunch of people, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less dear, than filing an individual suit. As a rule, filing a class action lawsuit won’t cost anything unless there’s a settlement. At that point, the attorney who handled the suit will take his charges from the compensation that was given and then assign the leftover funds to the litigants in the case. Since this is the case, you’ll be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the explanations that class action lawsuits have become so popular.
The initial class action suit against Iovate was filed in Canada where the company is located and represents all Canadian citizens who sustained health problems due to Hydroxycut products. The FDA recall took place in the United States where 23 cases of liver disorders and other health issues had been reported. Health Canada failed to receive any reports of liver damage due to the diet products, but they did receive 17 reports concerning folks who sustained breathing, neurological, cardio, and gastrointestinal problems as a result of Canadians using the products.
The Hydroxycut class action suit alleges that the company sold the products without properly informing the public of the health risks that they could exposing buyers to. The complaint states that the company failed to publish the data on the product labels saying that users could run the chance of liver and kidney damage as well as gut, cardio, respiratory, and neurological issues. The suit goes on to allege that this was a blatant omission on the part of the company which deliberately misled consumers concerning the safety of the products.
